Regulus Therapeutics reported -0.05 in EPS Earnings Per Share for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Alnylam Pharmaceuticals ALNY:US $ -1.49 0.67
AstraZeneca AZN:LN 1.67 0.59
Astrazeneca AZN:US $ 1.89 1.05
Biogen BIIB:US $ 3.62 0.23
Celldex Therapeutics CLDX:US -0.49 0.06
Gilead Sciences GILD:US $ 2.12 1.43
GlaxoSmithKline GSK:LN 0.33 0.07
Intercept Pharmaceuticals ICPT:US $ -0.58 0.65
Intrexon XON:US $ -0.15 0.05
IONIS PHARMACEUT IONS:US $ 1.41 1.99
Lexicon Pharmaceuticals LXRX:US -0.16 0.01
Ligand Pharmaceuticals LGND:US $ 0.58 1.22
Merk MRK:US $ 2.14 0.34
Omeros OMER:US -0.53 0.16
Regulus Therapeutics RGLS:US -0.05 0.02
Sangamo Biosciences SGMO:US $ -0.3 0.04
Sanofi SNY:US $ 1.02 0.23
Spectrum Pharmaceuticals SPPI:US -0.08 0.18
Takeda 4502:JP Y 9 28.01
Vital Therapies VTL:US $ -0.74 0.02
YTE INCY:US $ 0.55 0.45